| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.887 | 0.004 | 0.887 | Antiadrenergic | 0.179 0.029 CID_162729 | ||
| 0.887 | 0.004 | 0.887 | Adrenaline antagonist | 0.176 0.028 CID_162729 | ||
| 0.819 | 0.004 | 0.892 | Vasodilator, coronary | 0.892 0.003 CID_162729 | CID_162729 | |
| 0.792 | 0.003 | 0.792 | Anesthetic local | 0.167 0.042 CID_162729 | ||
| 0.764 | 0.005 | 0.764 | Spasmolytic | 0.695 0.006 CID_162729 | ||
| 0.722 | 0.006 | 0.722 | 5 Hydroxytryptamine release stimulant | 0.488 0.029 CID_162729 | ||
| 0.699 | 0.005 | 0.699 | Cardiotonic | 0.342 0.041 CID_162729 | ||
| 0.688 | 0.007 | 0.688 | Vasodilator, peripheral | 0.586 0.018 CID_162729 | ||
| 0.557 | 0.008 | 0.557 | Vasodilator | 0.532 0.01 CID_162729 | ||
| 0.516 | 0.002 | 0.516 | Beta adrenoreceptor antagonist | 0.079 0.028 CID_162729 | ||
| 0.472 | 0.005 | 0.472 | DNA methyltransferase I inhibitor | 0.447 0.006 CID_162729 | ||
| 0.45 | 0.002 | 0.45 | Beta 2 adrenoreceptor antagonist | 0.056 0.028 CID_162729 | ||
| 0.454 | 0.011 | 0.454 | P-glycoprotein inhibitor | 0.228 0.049 CID_162729 | ||
| 0.451 | 0.008 | 0.493 | DNA methylase inhibitor | 0.493 0.006 CID_162729 | CID_162729 | |
| 0.501 | 0.059 | 0.501 | Caspase 9 stimulant | 0.483 0.067 CID_162729 | ||
| 0.472 | 0.049 | 0.769 | Transcription factor NF kappa B inhibitor | 0.769 0.015 CID_162729 | CID_162729 | |
| 0.425 | 0.011 | 0.425 | Sodium/bile acid cotransporter inhibitor | 0.354 0.037 CID_162729 | ||
| 0.444 | 0.042 | 0.652 | Cholesterol antagonist | 0.652 0.012 CID_162729 | CID_162729 | |
| 0.393 | 0.002 | 0.393 | Beta 1 adrenoreceptor antagonist | |||
| 0.391 | 0.003 | 0.391 | Adrenaline agonist | |||
| 0.41 | 0.047 | 0.748 | Antithrombotic | 0.748 0.006 CID_162729 | CID_162729 | |
| 0.369 | 0.008 | 0.369 | Insulin sensitizer | 0.234 0.044 CID_162729 | ||
| 0.347 | 0.013 | 0.416 | Peptidyltransferase inhibitor | 0.416 0.006 CID_162729 | CID_162729 | |
| 0.362 | 0.035 | 0.581 | Hypoglycemic | 0.581 0.009 CID_162729 | CID_162729 | |
| 0.386 | 0.069 | 0.508 | Immunosuppressant | 0.508 0.031 CID_162729 | CID_162729 | |
| 0.297 | 0.003 | 0.297 | Adenylate cyclase stimulant | 0.208 0.01 CID_162729 | ||
| 0.292 | 0.003 | 0.292 | Beta 3 adrenoreceptor antagonist | |||
| 0.32 | 0.034 | 0.32 | Cyclic AMP phosphodiesterase inhibitor | 0.289 0.046 CID_162729 | ||
| 0.342 | 0.057 | 0.342 | Aldehyde oxidase inhibitor | |||
| 0.345 | 0.061 | 0.353 | Caspase 3 stimulant | 0.353 0.058 CID_162729 | CID_162729 | |
| 0.318 | 0.036 | 0.318 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.285 | 0.01 | 0.285 | Nav1.3 sodium channel blocker | |||
| 0.278 | 0.009 | 0.394 | ATPase inhibitor | 0.394 0.004 CID_162729 | CID_162729 | |
| 0.375 | 0.106 | 0.62 | Cyclophilin D inhibitor | 0.62 0.024 CID_162729 | CID_162729 | |
| 0.367 | 0.101 | 0.367 | 5 Hydroxytryptamine release inhibitor | 0.314 0.15 CID_162729 | ||
| 0.333 | 0.069 | 0.585 | Immunostimulant | 0.585 0.018 CID_162729 | CID_162729 | |
| 0.289 | 0.041 | 0.289 | Gastrin inhibitor | 0.219 0.12 CID_162729 | ||
| 0.261 | 0.018 | 0.261 | Insulin secretagoues | 0.241 0.021 CID_162729 | ||
| 0.254 | 0.022 | 0.339 | Alpha-N-acetylglucosaminidase inhibitor | 0.339 0.013 CID_162729 | CID_162729 | |
| 0.336 | 0.106 | 0.425 | Histamine release inhibitor | 0.425 0.063 CID_162729 | CID_162729 | |
| 0.273 | 0.051 | 0.273 | Psychostimulant | 0.172 0.098 CID_162729 | ||
| 0.225 | 0.011 | 0.225 | Calcium antagonist | |||
| 0.304 | 0.113 | 0.304 | GABA C receptor rho-3 antagonist | |||
| 0.209 | 0.02 | 0.209 | Toll-Like receptor 2 antagonist | 0.109 0.091 CID_162729 | ||
| 0.219 | 0.032 | 0.219 | Interleukin 6 antagonist | 0.155 0.082 CID_162729 | ||
| 0.301 | 0.116 | 0.301 | Antiobesity | 0.206 0.201 CID_162729 | ||
| 0.21 | 0.026 | 0.21 | Calcium channel blocker | |||
| 0.182 | 0.003 | 0.182 | Beta adrenoreceptor agonist | |||
| 0.328 | 0.153 | 0.573 | Apoptosis agonist | 0.573 0.055 CID_162729 | CID_162729 | |
| 0.246 | 0.077 | 0.246 | Superoxide dismutase inhibitor | |||
| 0.199 | 0.05 | 0.199 | Succinate dehydrogenase inhibitor | |||
| 0.167 | 0.024 | 0.167 | Mucolytic | 0.15 0.033 CID_162729 | ||
| 0.235 | 0.092 | 0.529 | Antioxidant | 0.529 0.017 CID_162729 | CID_162729 | |
| 0.216 | 0.073 | 0.216 | ErbB-1 antagonist | |||
| 0.243 | 0.103 | 0.243 | Insulysin inhibitor | |||
| 0.229 | 0.102 | 0.229 | Transcription factor STAT3 inhibitor | |||
| 0.158 | 0.032 | 0.3 | Expectorant | 0.3 0.009 CID_162729 | CID_162729 | |
| 0.183 | 0.058 | 0.183 | Phospholipase C inhibitor | 0.153 0.1 CID_162729 | ||
| 0.126 | 0.003 | 0.126 | Calcium-sensing receptor antagonist | |||
| 0.133 | 0.013 | 0.133 | Calcium channel L-type blocker | |||
| 0.159 | 0.042 | 0.159 | Aldehyde dehydrogenase inhibitor | 0.118 0.073 CID_162729 | ||
| 0.142 | 0.025 | 0.19 | Toll-Like receptor 4 antagonist | 0.19 0.008 CID_162729 | CID_162729 | |
| 0.204 | 0.091 | 0.272 | Hypolipemic | 0.272 0.058 CID_162729 | CID_162729 | |
| 0.117 | 0.005 | 0.117 | Sphingosine 1-phosphate receptor 3 agonist | |||
| 0.141 | 0.031 | 0.141 | Gastric antisecretory | |||
| 0.128 | 0.02 | 0.128 | Ornithine decarboxylase inhibitor | |||
| 0.169 | 0.061 | 0.169 | Diuretic | 0.165 0.065 CID_162729 | ||
| 0.227 | 0.121 | 0.227 | Hypoxia-inducible factor 1 alpha inhibitor | 0.193 0.16 CID_162729 | ||
| 0.14 | 0.035 | 0.14 | Bronchodilator | |||
| 0.142 | 0.036 | 0.142 | Nav1.1 sodium channel blocker | |||
| 0.145 | 0.043 | 0.145 | Vanilloid 1 agonist | 0.135 0.058 CID_162729 | ||
| 0.131 | 0.031 | 0.131 | GABA C receptor rho-1 antagonist | |||
| 0.196 | 0.096 | 0.196 | Nitric-oxide synthase stimulant | |||
| 0.133 | 0.033 | 0.133 | Sphingomyelinase inhibitor | 0.113 0.047 CID_162729 | ||
| 0.167 | 0.068 | 0.167 | Arachidonic acid antagonist | |||
| 0.127 | 0.029 | 0.127 | MAP kinase kinase 1 inhibitor | |||
| 0.131 | 0.033 | 0.131 | Alpha 2 adrenoreceptor antagonist | |||
| 0.119 | 0.022 | 0.119 | Histamine H2 receptor antagonist | |||
| 0.145 | 0.048 | 0.145 | Adenylate cyclase inhibitor | |||
| 0.11 | 0.015 | 0.11 | Cathepsin D inhibitor | |||
| 0.22 | 0.13 | 0.22 | 12-Lipoxygenase inhibitor | |||
| 0.141 | 0.051 | 0.141 | Proteasome inhibitor | |||
| 0.124 | 0.035 | 0.124 | Factor V inhibitor | 0.095 0.081 CID_162729 | ||
| 0.127 | 0.038 | 0.127 | Adenylate kinase inhibitor | |||
| 0.093 | 0.005 | 0.093 | Beta 2 adrenoreceptor agonist | |||
| 0.208 | 0.121 | 0.208 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.15 | 0.068 | 0.241 | Lipid peroxidase inhibitor | 0.241 0.029 CID_162729 | CID_162729 | |
| 0.142 | 0.062 | 0.142 | Nav1.2 sodium channel blocker | |||
| 0.13 | 0.051 | 0.17 | Microtubule formation inhibitor | 0.17 0.029 CID_162729 | CID_162729 | |
| 0.123 | 0.045 | 0.204 | Mediator release inhibitor | 0.204 0.014 CID_162729 | CID_162729 | |
| 0.125 | 0.048 | 0.125 | GABA C receptor antagonist | |||
| 0.15 | 0.074 | 0.15 | Acetylcholine M1 receptor antagonist | |||
| 0.153 | 0.077 | 0.184 | Melanin inhibitor | 0.184 0.049 CID_162729 | CID_162729 | |
| 0.157 | 0.082 | 0.157 | Growth hormone agonist | |||
| 0.151 | 0.076 | 0.251 | Interferon gamma antagonist | 0.251 0.028 CID_162729 | CID_162729 | |
| 0.12 | 0.048 | 0.12 | Protease inhibitor | |||
| 0.198 | 0.127 | 0.356 | DNA synthesis inhibitor | 0.356 0.029 CID_162729 | CID_162729 | |
| 0.118 | 0.048 | 0.118 | Alpha adrenoreceptor antagonist | |||
| 0.089 | 0.02 | 0.089 | 5 Hydroxytryptamine 2A agonist | |||
| 0.097 | 0.027 | 0.097 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.101 | 0.033 | 0.101 | Somatostatin 1 agonist | |||
| 0.096 | 0.029 | 0.346 | Selectin antagonist | 0.346 0.004 CID_162729 | CID_162729 | |
| 0.178 | 0.111 | 0.178 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.075 | 0.009 | 0.075 | Squalene synthetase inhibitor | 0.075 0.009 CID_162729 | ||
| 0.102 | 0.038 | 0.102 | Catalase inhibitor | |||
| 0.155 | 0.091 | 0.389 | Nitric oxide antagonist | 0.389 0.027 CID_162729 | CID_162729 | |
| 0.1 | 0.037 | 0.1 | Glutathione S-transferase inhibitor | |||
| 0.075 | 0.012 | 0.075 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.219 | 0.157 | 0.471 | Apoptosis antagonist | 0.471 0.024 CID_162729 | CID_162729 | |
| 0.105 | 0.043 | 0.154 | Triose-phosphate isomerase inhibitor | 0.154 0.019 CID_162729 | CID_162729 | |
| 0.244 | 0.183 | 0.609 | Antibacterial | 0.609 0.018 CID_162729 | CID_162729 | |
| 0.077 | 0.02 | 0.077 | Fibroblast growth factor 4 antagonist | |||
| 0.078 | 0.022 | 0.078 | Ornithine carbamoyltransferase inhibitor | |||
| 0.086 | 0.03 | 0.086 | Fibroblast growth factor 2 antagonist | |||
| 0.092 | 0.036 | 0.092 | Keratolytic | |||
| 0.08 | 0.025 | 0.113 | Neuraminidase inhibitor | 0.113 0.011 CID_162729 | CID_162729 | |
| 0.141 | 0.086 | 0.141 | GABA C receptor rho-2 antagonist | |||
| 0.091 | 0.036 | 0.091 | Glutamate dehydrogenase inhibitor | |||
| 0.13 | 0.075 | 0.361 | Amylase inhibitor | 0.361 0.012 CID_162729 | CID_162729 | |
| 0.061 | 0.006 | 0.061 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.12 | 0.068 | 0.217 | Alkylator | 0.217 0.022 CID_162729 | CID_162729 | |
| 0.056 | 0.005 | 0.056 | Plasmepsin I inhibitor | |||
| 0.062 | 0.012 | 0.062 | Sphingosine 1-phosphate receptor 1 agonist | |||
| 0.086 | 0.037 | 0.086 | Aminopeptidase I inhibitor | |||
| 0.053 | 0.004 | 0.053 | Beta 1 adrenoreceptor agonist | |||
| 0.068 | 0.019 | 0.068 | 5 Hydroxytryptamine 1B agonist | |||
| 0.102 | 0.055 | 0.102 | Electrolyte absorption antagonist | |||
| 0.088 | 0.043 | 0.111 | Na+ K+ transporting ATPase inhibitor | 0.111 0.022 CID_162729 | CID_162729 | |
| 0.081 | 0.035 | 0.081 | Secretase beta inhibitor | |||
| 0.112 | 0.067 | 0.112 | Calcium channel (voltage-sensitive) blocker | |||
| 0.058 | 0.013 | 0.058 | Plasmepsin II inhibitor | |||
| 0.179 | 0.135 | 0.179 | DNA damaging | 0.174 0.14 CID_162729 | ||
| 0.083 | 0.042 | 0.083 | Glutamate decarboxylase inhibitor | |||
| 0.101 | 0.061 | 0.101 | Anabolic | |||
| 0.058 | 0.018 | 0.058 | Sphingosine 1-phosphate receptor agonist | |||
| 0.069 | 0.031 | 0.069 | Calcium channel P-type blocker | |||
| 0.088 | 0.054 | 0.149 | Transcription factor NF kappa B stimulant | 0.149 0.016 CID_162729 | CID_162729 | |
| 0.064 | 0.03 | 0.064 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.066 | 0.033 | 0.066 | Cathepsin E inhibitor | |||
| 0.076 | 0.044 | 0.137 | Phosphofructokinase-1 inhibitor | 0.137 0.021 CID_162729 | CID_162729 | |
| 0.067 | 0.04 | 0.122 | Neuraminidase (influenza) inhibitor | 0.122 0.011 CID_162729 | CID_162729 | |
| 0.128 | 0.101 | 0.128 | Thiol protease inhibitor | |||
| 0.05 | 0.024 | 0.06 | Neuraminidase (Influenza A) inhibitor | 0.06 0.013 CID_162729 | CID_162729 | |
| 0.1 | 0.074 | 0.1 | Alpha 2b adrenoreceptor antagonist | |||
| 0.058 | 0.032 | 0.058 | Epithelial sodium channel blocker | |||
| 0.11 | 0.084 | 0.11 | MAP kinase kinase inhibitor | |||
| 0.129 | 0.103 | 0.13 | Phospholipase A2 inhibitor | 0.13 0.101 CID_162729 | CID_162729 | |
| 0.128 | 0.104 | 0.128 | Neuropeptide Y1 antagonist | |||
| 0.027 | 0.004 | 0.027 | Beta 3 adrenoreceptor agonist | |||
| 0.158 | 0.135 | 0.464 | Free radical scavenger | 0.464 0.02 CID_162729 | CID_162729 | |
| 0.028 | 0.005 | 0.028 | Neuraminidase (Influenza B) inhibitor | |||
| 0.064 | 0.042 | 0.072 | Nitric oxide donor | 0.072 0.031 CID_162729 | CID_162729 | |
| 0.115 | 0.094 | 0.115 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.074 | 0.053 | 0.074 | Vanilloid 4 agonist | |||
| 0.103 | 0.083 | 0.103 | Cholesterol synthesis inhibitor | |||
| 0.056 | 0.037 | 0.056 | Sphingosine kinase 2 inhibitor | |||
| 0.09 | 0.073 | 0.09 | Aminopeptidase B inhibitor | |||
| 0.098 | 0.081 | 0.098 | Chelator | 0.096 0.083 CID_162729 | ||
| 0.083 | 0.068 | 0.154 | NADH dehydrogenase inhibitor | 0.154 0.016 CID_162729 | CID_162729 | |
| 0.058 | 0.043 | 0.058 | Sphingosine kinase inhibitor | |||
| 0.086 | 0.071 | 0.094 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.094 0.061 CID_162729 | CID_162729 | |
| 0.031 | 0.017 | 0.031 | Uridine phosphorylase inhibitor | 0.031 0.017 CID_162729 | ||
| 0.166 | 0.152 | 0.304 | Interleukin agonist | 0.304 0.046 CID_162729 | CID_162729 | |
| 0.081 | 0.067 | 0.081 | Vanilloid agonist | |||
| 0.027 | 0.014 | 0.027 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.054 | 0.042 | 0.054 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | |||
| 0.116 | 0.104 | 0.116 | Peroxidase inhibitor | |||
| 0.085 | 0.074 | 0.09 | Glutamate release inhibitor | 0.09 0.061 CID_162729 | CID_162729 | |
| 0.083 | 0.071 | 0.096 | ATPase (Vacuolar H+) inhibitor | 0.096 0.045 CID_162729 | CID_162729 | |
| 0.088 | 0.077 | 0.167 | UDP-glucose 4-epimerase inhibitor | 0.167 0.024 CID_162729 | CID_162729 | |
| 0.082 | 0.073 | 0.082 | Aminoacyl-tRNA synthetase inhibitor | |||
| 0.057 | 0.047 | 0.057 | Gonadotropin-releasing hormone receptor agonist | |||
| 0.041 | 0.033 | 0.041 | HIV-1 protease inhibitor | |||
| 0.017 | 0.01 | 0.017 | Vitamin D receptor agonist | |||
| 0.157 | 0.15 | 0.391 | Tumour necrosis factor alpha release inhibitor | 0.391 0.028 CID_162729 | CID_162729 | |
| 0.062 | 0.056 | 0.062 | Sirtuin 1 inhibitor | |||
| 0.05 | 0.044 | 0.05 | Myc inhibitor | |||
| 0.059 | 0.053 | 0.059 | Phosphodiesterase III inhibitor | |||
| 0.059 | 0.054 | 0.059 | 5 Hydroxytryptamine 1A antagonist | |||
| 0.177 | 0.172 | 0.177 | Transcription factor STAT inhibitor | |||
| 0.112 | 0.108 | 0.112 | Nav1.6 sodium channel blocker | |||
| 0.021 | 0.018 | 0.021 | Prostaglandin F2 alpha agonist | |||
| 0.135 | 0.131 | 0.157 | Anesthetic general | 0.157 0.107 CID_162729 | CID_162729 | |
| 0.066 | 0.063 | 0.066 | Alpha 2a adrenoreceptor antagonist | |||
| 0.029 | 0.028 | 0.029 | Methionyl aminopeptidase 1 inhibitor | |||
| 0.048 | 0.048 | 0.062 | Alpha-mannosidase inhibitor | 0.062 0.024 CID_162729 | CID_162729 | |
| 0.065 | 0.067 | 0.108 | Topoisomerase II alpha inhibitor | 0.108 0.035 CID_162729 | CID_162729 | |
| 0.11 | 0.116 | 0.228 | Cell wall synthesis inhibitor | 0.228 0.021 CID_162729 | CID_162729 | |
| 0.041 | 0.048 | 0.049 | Glucose-6-phosphate isomerase inhibitor | 0.049 0.03 CID_162729 | CID_162729 | |
| 0.037 | 0.047 | 0.055 | Mannosidase inhibitor | 0.055 0.02 CID_162729 | CID_162729 | |
| 0.189 | 0.209 | 0.424 | Interleukin 2 agonist | 0.424 0.021 CID_162729 | CID_162729 | |
| 0.1 | 0.122 | 0.124 | Protein kinase stimulant | 0.124 0.089 CID_162729 | CID_162729 | |
| 0.081 | 0.103 | 0.095 | Phosphodiesterase 6D inhibitor | 0.095 0.062 CID_162729 | CID_162729 | |
| 0.137 | 0.16 | 0.263 | Platelet antagonist | 0.263 0.067 CID_162729 | CID_162729 | |
| 0.092 | 0.116 | 0.194 | Cyclooxygenase 3 inhibitor | 0.194 0.021 CID_162729 | CID_162729 | |
| 0.014 | 0.037 | 0.026 | Antibiotic Anthracycline-like | 0.026 0.005 CID_162729 | CID_162729 | |
| 0.122 | 0.148 | 0.391 | Hepatoprotectant | 0.391 0.014 CID_162729 | CID_162729 | |
| 0.103 | 0.131 | 0.242 | Thrombolytic | 0.242 0.036 CID_162729 | CID_162729 | |
| 0.058 | 0.09 | 0.072 | GABA aminotransferase inhibitor | 0.072 0.058 CID_162729 | CID_162729 | |
| 0.114 | 0.148 | 0.545 | Angiogenesis stimulant | 0.545 0.009 CID_162729 | CID_162729 | |
| 0.032 | 0.067 | 0.046 | Microtubule stabilization | 0.046 0.033 CID_162729 | CID_162729 | |
| 0.167 | 0.207 | 0.415 | Immunomodulator | 0.415 0.04 CID_162729 | CID_162729 | |
| 0.073 | 0.115 | 0.111 | Protein-tyrosine phosphatase 1B inhibitor | 0.111 0.069 CID_162729 | CID_162729 | |
| 0.014 | 0.061 | 0.053 | Sodium/glucose cotransporter 2 inhibitor | 0.053 0.006 CID_162729 | CID_162729 | |
| 0.071 | 0.121 | 0.113 | Xanthine oxidase inhibitor | 0.113 0.051 CID_162729 | CID_162729 | |
| 0.024 | 0.077 | 0.063 | Antibiotic Aminoglycoside-like | 0.063 0.008 CID_162729 | CID_162729 | |
| 0.015 | 0.071 | 0.044 | Sodium/glucose cotransporter inhibitor | 0.044 0.006 CID_162729 | CID_162729 | |
| 0.08 | 0.139 | 0.109 | Photosensitizer | 0.109 0.072 CID_162729 | CID_162729 | |
| 0.087 | 0.147 | 0.131 | Interleukin 4 antagonist | 0.131 0.071 CID_162729 | CID_162729 | |
| 0.055 | 0.117 | 0.236 | Monophenol monooxygenase inhibitor | 0.236 0.026 CID_162729 | CID_162729 | |
| 0.033 | 0.115 | 0.166 | Antineoplastic antibiotic | 0.166 0.027 CID_162729 | CID_162729 | |
| 0.088 | 0.2 | 0.22 | NOS3 expression enhancer | 0.22 0.034 CID_162729 | CID_162729 | |
| 0.101 | 0.216 | 0.236 | Antiamyloidogenic | 0.236 0.077 CID_162729 | CID_162729 | |
| 0.029 | 0.146 | 0.065 | Glucose-6-phosphate translocase inhibitor | 0.065 0.02 CID_162729 | CID_162729 | |
| 0.011 | 0.129 | 0.033 | Protein 30S ribosomal subunit inhibitor | 0.033 0.012 CID_162729 | CID_162729 | |
| 0.087 | 0.208 | 0.319 | Platelet adhesion inhibitor | 0.319 0.028 CID_162729 | CID_162729 | |
| 0.021 | 0.146 | 0.091 | Protein 50S ribosomal subunit inhibitor | 0.091 0.015 CID_162729 | CID_162729 | |
| 0.072 | 0.208 | 0.14 | Amyloid beta aggregation inhibitor | 0.14 0.116 CID_162729 | CID_162729 | |
| 0.016 | 0.174 | 0.032 | Toll-Like receptor 4 agonist | 0.032 0.009 CID_162729 | CID_162729 | |
| 0.034 | 0.199 | 0.079 | Adenine nucleotide translocase inhibitor | 0.079 0.009 CID_162729 | CID_162729 | |
| 0.041 | 0.214 | 0.142 | Topoisomerase II inhibitor | 0.142 0.053 CID_162729 | CID_162729 | |
| 0.048 | 0.224 | 0.123 | DNA polymerase I inhibitor | 0.123 0.066 CID_162729 | CID_162729 | |
| 0.074 | 0.276 | 0.283 | Hemostatic | 0.283 0.018 CID_162729 | CID_162729 | |
| 0.039 | 0.247 | 0.086 | Uric acid excretion stimulant | 0.086 0.072 CID_162729 | CID_162729 | |
| 0.053 | 0.278 | 0.159 | Cell adhesion inhibitor | 0.159 0.041 CID_162729 | CID_162729 | |
| 0.038 | 0.278 | 0.141 | AMP-activated protein kinase stimulant | 0.141 0.034 CID_162729 | CID_162729 | |
| 0.026 | 0.273 | 0.136 | Topoisomerase I inhibitor | 0.136 0.047 CID_162729 | CID_162729 | |
| 0.034 | 0.283 | 0.055 | Lipocortins synthesis agonist | 0.055 0.049 CID_162729 | CID_162729 | |
| 0.089 | 0.359 | 0.238 | Angiogenesis inhibitor | 0.238 0.132 CID_162729 | CID_162729 | |
| 0.08 | 0.362 | 0.335 | Alpha-glucosidase inhibitor | 0.335 0.143 CID_162729 | CID_162729 | |
| 0.019 | 0.308 | 0.066 | Heparanase inhibitor | 0.066 0.015 CID_162729 | CID_162729 | |
| 0.038 | 0.366 | 0.167 | Anticoagulant | 0.167 0.068 CID_162729 | CID_162729 | |
| 0.028 | 0.358 | 0.074 | Cell adhesion molecule inhibitor | 0.074 0.061 CID_162729 | CID_162729 | |
| 0.108 | 0.508 | 0.591 | Antiinflammatory | 0.591 0.056 CID_162729 | CID_162729 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |